Combination of DPP-IV inhibitor and a cannabinoid CB1 receptor antagonist

Details for Australian Patent Application No. 2006268650 (hide)

Owner Novartis AG

Inventors Milosavljevic-Ristic, Smiljana

Agent Davies Collison Cave

Pub. Number AU-A-2006268650

PCT Pub. Number WO2007/006790

Priority 60/698,304 12.07.05 US

Filing date 11 July 2006

Wipo publication date 18 January 2007

International Classifications

A61K 31/401 (2006.01) - Proline

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/006790 Priority application(s): WO2007/006790

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268651-Method for calibrating machines for the analysis of characteristic parameters of the blood connected to its density, such as erythrocyte sedimentation rate and/ or red corpuscles aggregation rate

2006268644-Methods and apparatus for acquisition of marine seismic data